A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease modelsBettina van Lengerich, Karin Wind, Kathryn M. Monroe et al.|Nature Neuroscience|2023Cited by 227
CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 95
Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIAMichelle E. Pizzo, Y. Joy Yu Zuchero, Edward D. Plowey et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 13
Author Correction: CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 2